ERIDES ER-50 is one of the trusted brands of Desvenlafaxine Extended Release Tablets. This tablet contains 50mg of desvenlafaxine extended release, which belongs to the Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) class. Desvenlafaxine works by inhibiting the reuptake of serotonin and norepinephrine in the brain. This increases the levels of these neurotransmitters, which helps improve mood, emotional stability, sleep, and energy levels.
This effective tablet is primarily used for the treatment of Major Depressive Disorder (MDD), and helps to improve mood, energy level, interest in daily activities, and overall mental well-being. The extended-release formulation of ERIDES ER-50 tablet ensures controlled and sustained release of the medicine throughout the day, and provides consistent therapeutic effect with once-daily dosing.
Overall, this effective Desvenlafaxine Extended Release Tablets is manufactured under WHO-GMP compliant manufacturing facilities following strict quality control standards to ensure safety, efficacy, and consistent product quality.
Uses of Desvenlafaxine Extended Release Tablets
ERIDES ER-50 tablets are used for:
- Major Depressive Disorder (MDD) – Severe or long-term depression
- Anxiety associated with depression– feeling anxious along wth depression
- Stress-related disorders– mental stress and emotional pressure conditions
- Mood disorders– mood swings and emotional imbalance.
- Panic symptoms– sudden fear, panic attacks, and nervousness.
- Social anxiety disorder– fear of social situations or public interaction.
Key Benefits of ERIDES ER-50 Tablets
- Effective treatment for depression
- Improves mood and emotional balance
- Helps reduce anxiety and stress
- Improves sleep pattern
- Enhances energy and daily activity performance
- Extended-release formulation for once-daily dosing
- Better patient compliance
- Suitable for long-term management under medical supervision
Dosage & Storage of Desvenlafaxine Tablets
ERIDES ER-50 is usually taken once daily or as directed by the physician. Swallow the tablet whole with water and do not crush, chew, or break the extended-release tablet, as it is designed to release the medicine slowly. Try to take the medicine at the same time every day for better results. Store the tablets in a cool and dry place below 25°C, away from direct sunlight and moisture. Always keep the medicine out of reach of children.
Precautions for Desvenlafaxine Extended Release Tablets
- Use this tablet only under medical supervision, especially for depression and mood disorders.
- Do not stop the medicine suddenly, as it may cause withdrawal symptoms, such as dizziness, irritability, headache, and sleep problems.
- Inform your doctor if you have liver disease, kidney disease, heart disease, high blood pressure, or glaucoma.
- ERIDES ER-50 tablet may increase blood pressure, so regular monitoring of blood pressure is recommended.
- Avoid alcohol while taking this medicine, as it may increase dizziness and drowsiness.
- Do not crush or chew the extended-release tablet; swallow it whole.
- If you experience suicidal thoughts, mood changes, or unusual behaviour, contact a doctor immediately.
Desvenlafaxine Extended Release 50 mg Tablets Manufacturer, Supplier, PCD Pharma Franchise - Eridanus Healthcare
Eridanus Healthcare is a trusted name in the pharmaceutical industry, offering high-quality Desvenlafaxine Extended Release 50 mg Tablets under the brand name ERIDES ER-50. The company is known for its commitment to quality, safety, and effective formulations that meet modern healthcare standards.
As a reliable manufacturer of Desvenlafaxine Extended Release Tablets, Eridanus Healthcare ensures that ERIDES ER-50 is manufactured in GMP-certified facilities using advanced technology and strict quality control processes. The company also maintains a strong supply chain network to ensure consistent product availability and timely delivery across different regions.
For entrepreneurs and distributors, Eridanus Healthcare offers excellent PCD Pharma Franchise and third-party manufacturing opportunities for ERIDES ER-50, along with monopoly rights, promotional support, and attractive business margins. Partnering with Eridanus Healthcare means working with a company that believes in quality, transparency, and long-term business growth in the pharmaceutical sector.
FAQs (Frequently Asked Questions)
Does Eridanus Healthcare offer a PCD Pharma Franchise for ERIDES ER-50?
Yes, our company offers PCD Pharma Franchise opportunities for ERIDES ER-50 with monopoly rights, promotional support, and attractive business margins.
Does the company provide third-party manufacturing for ERIDES ER-50?
Yes, Eridanus Healthcare provides third-party manufacturing services with customised packaging and private labelling options.
What documents are provided with the ERIDES ER-50 supply?
The company provides documents such as COA (Certificate of Analysis), GST Invoice, Product Permission, and Batch Details.
Why is extended-release Desvenlafaxine preferred in long-term depression treatment?
Extended-release Desvenlafaxine provides a consistent therapeutic effect, reduces fluctuations in drug levels, improves patient compliance, and is more suitable for long-term management of Major Depressive Disorder.
